Operational excellence in technology transfer: Connect to Frankfurt on-demand
.png)
In this Connect to Frankfurt session, Clarissa J. Van Allen, Global Senior Manager, Technology Transfer, Oral Solid Dose at Thermo Fisher Scientific (Des Moines, USA), discusses the value of an effective and efficient technology transfer project in the drug development and commercialization process, and how Thermo Fisher offers solutions to tech transfer project management.
As part of our conference track devoted to Future Therapies, this session explores technology transfer project management with leading experts in the drug devleopment and commercialization industry.
Technology transfer project management: why is it important?
Technology transfer refers to the process by which an original innovator makes their production technology available to commercial partners, including any aspects of the drug production process and business processes. Internal technology transfers occur between a drug’s development and commercial stages within the same organization, while external technology transfers are from an external developer to a commercial-scale manufacturing facility. technology transfers constitute a crucial part of the progression of a successful product – from its discovery, development, and clinical testing right through to a products full-scale commercialization.
Van Allen’s presentation emphasized the importance of an effective and efficient technology transfer project management strategy.
The right method for consistent and reliable technology transfer execution
In her presentation, Van Allen highlighted some key parameters for ensuring a technology transfer project’s success. A robust methodology was at the centre of Van Allen’s strategy for rapid and predictable delivery of technology transfer project timelines and expectations. The key points she discussed included:
1) Proactive risk mitigation.
Actions under this parameter included a documented action plan to resolve each risk and flagging support needs for each site and facility.
2) Optimized governance and escalation pathways stemming from site-level governance and global networks to troubleshoot and mitigate issues.
3) Local project review boards.
4) Seamless execution between project phases.
This should be achieved through dependable ‘right first-time’ delivery.
5) A single point-of-contact for seamless project management.
6) A global network of trusted partner’s throughout the development and commercial pipelines.
Van Allen also included Thermo Fisher Scientific’s suite of digital toolkits for enhanced process oversight in order to provide what she termed “trust, transparency, and accountability”.
Case studies
Two case studies were presented as part of Van Allen’s presentation. The first covered a small, multinational pharmaceutical company looking to produce a COVID-19 treatment in a three-month timeline. With limited resources, the company turned to Thermo Fisher Scientific to conduct multiple, concurrent technology transfer projects across three sites while meeting regulatory requirements for both the US and EU markets. With a single point-of-contact and internal information sharing across the sites, successful technology transfer projects were executed in the span of 4–6 months.
In another instance, the US FDA issued an emergency use authorization for COVID-19 dual tablet treatments. Speed-to-market was crucial to the technology transfer project for this case, as competitors of the client were in the process of developing similar products. By managing the technology transfer to commercialization in tandem with development activities, the team were able to deliver an effective COVID-19 treatment to market with efficiency and robustness and a successful launch.
The future of technology transfer
With an effective execution strategy and robust methodology, Van Allen emphasized the value of technology transfer programs as an integral part of drug development and commercialization. With appropriate tools and management systems, technology transfers can aid in synergising complimentary needs at every step of a product’s development through to its launch in the global market.
Discover more Connect to Frankfurt 2022 on-demand sessions here.
Related News
-
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. -
News CPHI Podcast Series: Packaging expert perspectives at Pharmapack 2025
This month's podcast episode sounds a little different, covering the latest event in Paris – Pharmapack 2025. Digital Editor Lucy Chard speaks to several experts direct from the floor of the show, bringing you right in on the action.&nbs... -
News Closing 2024 with Editors' picks of top articles from the past year
Coming to the end of 2024 and it’s certainly been a busy year, for CPHI and for the rest of the pharmaceutical and healthcare industry. Topics of conversation throughout the last 12 months have been varied, touching on the technical, to the polit... -
News SCHOTT Pharma’s sustainable journey with CPHI
Sustainability is of paramount importance in the pharmaceutical industry. See how a recent partnership between CPHI and SCHOTT Pharma has helped to highlight and accelerate their sustainability journey to reach global goals. -
News CPHI Podcast Series: Investing in a vision for the future of life sciences
In this episode Lucy Chard is joined by Rajiv Khatau to discuss the importance of looking into new therapeutic areas and some of the more niche areas of pharmaceuticals, and investing in the future of the industry. -
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News Women in Pharma: Reflections from Behind the Scenes
In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance